Elisabet Casellas‐Pujol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisabet Casellas‐Pujol has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ana Martín-Blanco
Department of Psychiatry and Legal Medicine Universitat Autònoma de Barcelona Barcelona Spain
1 shared publication David Almenta
Department of Psychiatry Hospital de la Santa Creu i Sant Pau Barcelona Spain
1 shared publicationIsabel Fernández‐Felipe
Labpsitec Laboratorio de Psicología y Tecnología. Dpto. Psicología Básica Clínica y Psicobiología Universitat Jaume I Castelló Spain
1 shared publication- Joaquim Soler
Universitat Autónoma de Barcelona
1 shared publication - Juan Carlos Pascual
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Institut de Recerca Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 4 February 2022
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 145 (4) , 332-342
“Skills for pills”: The dialectical‐behavioural therapy skills training reduces polypharmacy in borderline personality disorder
Objective: Polypharmacy and overprescription of off‐label medications are common in patients with borderline personality disorder (BPD). The aim of the present naturalistic study was to explore whether the skills training module of dialectical‐behavioural therapy (DBT) can reduce polypharmacy in these patients in routine clinical practice.Methods: Retrospective, observational study of 377 patients with a primary diagnosis of BPD consecutively admitted to the BPD outpatient unit from 2010 through 2020. All patients were invited to participate in the DBT skills training module (DBT‐ST). DBT‐ST participants (n = 182) were compared with a control group who did not participate in DBT‐ST (n = 195). Pre‐post intervention changes in medication load and use of antidepressants, benzodiazepines, mood stabilizers, and antipsychotics were evaluated.Results: At baseline, most patients (84.4%) were taking at least one medication and 46.9% were on polypharmacy. Compared to controls, patients in the DBT‐ST group presented a significant reduction in the number of medications (2.67–1.95 vs. 2.16–2.19; p < 0.001), medication load (4.25–3.05 vs. 3.45–3.48; p < 0.001), use of benzodiazepines (54.4%–27.5% vs. 40%–40.5%; p < 0.001), mood stabilizers (43.4%–33% vs. 36.4%–39.5%; p < 0.001), and antipsychotics (36.3%–29.1% vs. 34.4%–36.9%; p < 0.001).Conclusions: These findings suggest that patients with BPD can benefit from the DBT‐ST module, which may reduce the medication load, particularly of sedatives. The results suggest that DBT‐ST may be useful to treat overmedication in patients with BPD and could help to promote “deprescription” in clinical practice.
- 4 February 2022
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 145 (4) , 332-342
Open Access“Skills for pills”: The dialectical‐behavioural therapy skills training reduces polypharmacy in borderline personality disorder
Objective: Polypharmacy and overprescription of off‐label medications are common in patients with borderline personality disorder (BPD). The aim of the present naturalistic study was to explore whether the skills training module of dialectical‐behavioural therapy (DBT) can reduce polypharmacy in these patients in routine clinical practice.Methods: Retrospective, observational study of 377 patients with a primary diagnosis of BPD consecutively admitted to the BPD outpatient unit from 2010 through 2020. All patients were invited to participate in the DBT skills training module (DBT‐ST). DBT‐ST participants (n = 182) were compared with a control group who did not participate in DBT‐ST (n = 195). Pre‐post intervention changes in medication load and use of antidepressants, benzodiazepines, mood stabilizers, and antipsychotics were evaluated.Results: At baseline, most patients (84.4%) were taking at least one medication and 46.9% were on polypharmacy. Compared to controls, patients in the DBT‐ST group presented a significant reduction in the number of medications (2.67–1.95 vs. 2.16–2.19; p < 0.001), medication load (4.25–3.05 vs. 3.45–3.48; p < 0.001), use of benzodiazepines (54.4%–27.5% vs. 40%–40.5%; p < 0.001), mood stabilizers (43.4%–33% vs. 36.4%–39.5%; p < 0.001), and antipsychotics (36.3%–29.1% vs. 34.4%–36.9%; p < 0.001).Conclusions: These findings suggest that patients with BPD can benefit from the DBT‐ST module, which may reduce the medication load, particularly of sedatives. The results suggest that DBT‐ST may be useful to treat overmedication in patients with BPD and could help to promote “deprescription” in clinical practice.